{{Rsnum
|rsid=756777
|Gene=VAV2
|Chromosome=9
|position=133813958
|Orientation=plus
|GMAF=0.2309
|Gene_s=VAV2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 65.5 | 31.9 | 2.7
| HCB | 86.1 | 13.9 | 0.0
| JPT | 92.9 | 7.1 | 0.0
| YRI | 18.4 | 49.0 | 32.7
| ASW | 31.6 | 49.1 | 19.3
| CHB | 86.1 | 13.9 | 0.0
| CHD | 84.4 | 15.6 | 0.0
| GIH | 60.4 | 36.6 | 3.0
| LWK | 31.8 | 47.3 | 20.9
| MEX | 51.7 | 41.4 | 6.9
| MKK | 45.5 | 48.7 | 5.8
| TSI | 67.6 | 32.4 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=G
  |Pval=1E-6
  |OR=.19
  |ORtxt=[0.11-0.26] unit increase
  |OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}